- Home
- products
- asia middle east
- drug design and development
Show results for
Refine by
Drug Design And Development Equipment Supplied In Asia Middle East
42 equipment items found
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
PROTAC-Proteolysis targeting chimera is a technology that induces the Ubiquitin-Proteasome System (UPS) to degrade the target protein. When the target protein (Protein of Interest (POI)) is ubiquitinated by the ligase of E1, E2, E3, the proteasome recognizes that part of the protein and degrades the protein. PROTAC is composed of a protein of interest, a ligand that binds to the E3 ligase, and ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
MolEQ designs novel compounds by optimizing multiple properties such as efficacy and toxicity of a lead ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
Agonist refers to substances that activate a specific target protein. It can easily be viewed as the opposite of inhibitor. Until now, Deargen's drug-target interaction (DTI) was predicted based on the binding affinity between the substance and the target protein, which causes barrier to distinguish between the inhibition and activation activity. In addition, the demand for agonist hit discovery ...
Manufactured by:Hunan Aslsen Technology Co., Ltd based inFurong District, CHINA
Name: BMK Glycidic Acid CAS 5449-12-7 Purity: 99% Type: Pharmaceutical Intermediates Appearance: White Powder Function: Pharmaceutical Intermediates: BMK Ethyl Glycidate is commonly used as an intermediate in drug synthesis for the preparation of precursors or active ingredients of some drugs. In the pharmaceutical field, organic synthesis intermediates are essential for drug development. Flavor ...
Manufactured by:Hunan Aslsen Technology Co., Ltd based inFurong District, CHINA
Name: BMK Ethyl Glycidate CAS 41232-97-7 Purity: 99% Type: Pharmaceutical Intermediates Appearance: Yellow Liquid; White Powder Function: Pharmaceutical Intermediates: BMK Ethyl Glycidate is commonly used as an intermediate in drug synthesis for the preparation of precursors or active ingredients of some drugs. In the pharmaceutical field, organic synthesis intermediates are essential for drug ...
Manufactured by:Suvoda based inConshohocken, PENNSYLVANIA (USA)
Full visibility and automated control. Extend your clinical trial command and control center with Suvoda’s integrated ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
To hinder or inhibit the function of proteins that cause disease, many pharmaceutical companies develop drugs called inhibitors. Each of the 20,000 proteins in the human body has its own unique functions. Depending on the function of the protein, it can be classified into enzyme proteins, ion channel proteins, transport proteins, defense proteins, and structural proteins. Problems with the ...
by:KoBioLabs based inGwanak-ro, Gwanak-gu, SOUTH KOREA
New Drug Development Focusing on Immune/Metabolic/Neurological. ...
Manufactured by:SHL Medical AG based inZug, SWITZERLAND
The development of the Precision Pen Injector (PPI) is a story of uncompromising dedication to meeting industry challenges. A Swedish company specializing in solutions for aesthetics and corrective treatment sought to introduce an autoinjector for its skin booster – a highly viscous hyaluronic acid formulation of several hundred centipoise. The company needed a device that could deliver ...
Manufactured by:Troikaa Pharmaceuticals Ltd. based inAhmedabad, INDIA
To provide therapeutically meaningful extended delivery of drugs, Troikaa has developed Duo Phase Technology. Through this technology, the drug dose is split judiciously into two components, where one part delivers the drug immediately and the other releases the drug in a sustained release pattern. Thus drug delivery is biphasic and ensures the requisite pharmacokinetic profile. Drugs developed ...
by:Theramx Inc. based inSeongnam-si, SOUTH KOREA
Drug delivery platform technology designed to maximize efficacy while simultaneously minimizing side effects of existing drugs by delivery to desired ...
Manufactured by:MitoImmune Therapeutics Inc. based inGangnam-gu, SOUTH KOREA
The blood-brain barrier (BBB) penetrating technology is essential to develop drugs for neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, ALS, and Huntington’s disease, which have high unmet medical needs. MitoImmune has developed BIM Technology, a central nervous system target technology, and is conducting R&D for the treatment of neurodegenerative disease. BIM ...
Manufactured by:Nanjing Deda New Materials Technology Co., Ltd. based inNanjing, CHINA
PMK ethyl glycidate is an important intermediate in pharmaceutical synthesis, particularly in the production of certain chemicals used in research and development. While PMK ethyl glycidate has legitimate industrial uses, it is crucial to emphasize that its use should comply with all applicable laws and regulations. Research and Development: PMK ethyl glycidate is utilized in pharmaceutical ...
Manufactured by:Nissan Chemical Corporation based inTokyo, JAPAN
This is an antihypercholesterolemic agent characteristic of having a strong LDL cholesterol reduction effect and causing less drug-interactions. It is recognized as one of the “Strong statins” in clinical practice. In Japan, it is distributed by Kowa Company, Limited. It has been launched in 30 countries, such as the United States and countries in Latin America, Europe and Asia. It is ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
DearDTI presents drug candidates with a good efficacy by predicting the binding affinity, based on information about the compound-protein ...
Manufactured by:SEQENS Group based inÉcully, FRANCE
Our Drug Delivery Solutions Business Unit coordinates our Custom Lipids activity. Seqens strongly believes in the potential of new cutting-edge technologies. In the pharmaceutical industry, lipids and polymers are core excipients in the development of drug delivery systems. Lipids and polymers can be used in most dosage forms as support vehicles, solubilizers, permeation enhancers, stabilizers, ...
Manufactured by:Mimetas B.V. based inLeiden, NETHERLANDS
Profiling and screening of your compounds with a high throughput barrier integrity assay on our established Caco-2 intestinal model. OrganoServices are available for multiple assays to allow compound profiling and/or screening in human-relevant, complex 3D tissue models. When developing new drugs, it is critical to understand the permeability, absorption, and transport mechanisms in relevant ...
Manufactured by:Relisys Medical Devices Limited based inRanga Reddy, INDIA
Highlighting Features: • Release-R™ is the first indigenously developed Drug Eluting Stent in India • The strut thickness for Release-R™ is 65 μm • Unique open and closed cells Stent Design on L 605 Cobalt Chromium Stent platform with strut locking mechanism. This offers excellent radial strength and minimum recoil • Improved stent apposition ...
by:Taiwan Liposome Company, Ltd. (TLC) based inNangang Distric, TAIWAN
TLC is using antibodies and antibody fragments attached to lipid encapsulated drugs to develop more effective therapies in oncology. These antibody-linked nanomedicines actively target specific tissues using binding interactions between a specific antibody and a target antigen on the surface of a particular cell type. Compared with passively targeted therapies, these nanomedicines are better able ...
Manufactured by:SEQENS Group based inÉcully, FRANCE
Our Drug Delivery Solutions Business Unit coordinates our Custom Polymers activity. Seqens strongly believes in the potential of new cutting-edge technologies. In the pharmaceutical industry, lipids and polymers are core excipients in the development of drug delivery systems. Lipids and polymers can be used in most dosage forms as support vehicles, solubilizers, permeation enhancers, stabilizers, ...